Business Context and Reporting Period
This Form 8-K is a current report filed by PharmAthene, Inc. (not Altimmune, Inc.) on August 29, 2008. The registrant is incorporated in Delaware and maintains its principal executive offices in Annapolis, Maryland. The filing serves to disclose a PowerPoint presentation intended for discussions with stockholders and interested persons.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a presentation rather than a financial statement. For detailed financial data, the registrant refers investors to its Form 10-K for the year ended December 31, 2007, and Form 10-Q for the quarter ended June 30, 2008.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is limited to the furnishing of an exhibit (Item 7.01) and the listing of that exhibit (Item 9.01).
Guidance, Outlook, and Risks
Management commentary is limited to a caution that the attached PowerPoint presentation should be read in the context of more detailed information in previously filed SEC documents. No specific guidance, outlook, risks, or contingencies are detailed within the text of this 8-K.
Key Facts for Investor Verification
- Verify the company name is PharmAthene, Inc., as the input metadata incorrectly listed Altimmune, Inc.
- Confirm the date of the report is August 29, 2008.
- Review the attached Exhibit 99.1 (PowerPoint Presentation) for the actual content intended for stockholder discussions.
- Consult the Form 10-K (2007) and Form 10-Q (Q2 2008) for the financial metrics referenced but not included in this filing.